脱灰骨マトリックス市場：製品、投与形態、用途、最終用途別-2024-2030年の世界予測

脱灰骨マトリックス市場規模は、2023年に6億7,114万米ドルと推定され、2024年には7億1,336万米ドルに達し、CAGR 6.54%で2030年には10億4,637万米ドルに達すると予測されています。

脱灰骨マトリックス（DBM）とは、同種骨のコラーゲンマトリックスから得られる骨移植片の一種で、酸抽出プロセスによってミネラル分が除去されたものです。この脱灰処理により、骨の成長因子、特に骨形態形成タンパク質（BMP）が露出するため、DBMは骨誘導性を有し、新たな骨形成を促進することができます。DBMの使用拡大の主な要因としては、骨修復・再生におけるその有効性、様々な整形外科手術、歯科手術、脊椎手術における移植片エクステンダーとしての役割、自家移植の必要性を減らす可能性、したがってドナー部位の罹患率を最小限に抑えることなどが挙げられます。しかし、DBM製剤によって骨誘導能にばらつきがあること、免疫原性反応の可能性があること、DBM製剤によってはコストが高いことなどが、DBM製剤の採用に大きな課題をもたらしています。これらの制約に対処するため、現在進行中の調査や技術的進歩は、DBM製剤の一貫性と骨誘導能を高めることに重点を置いています。この戦略には、DBMを合成または天然の生体材料と組み合わせて構造的・機能的特性を向上させる複合移植片の開発や、安全性を確保しながら生物学的活性を維持するための高度な加工・滅菌技術の応用などが含まれます。新興地域における用途の拡大と次世代生物製剤との統合は、DBMのダイナミックな成長の道を示すものであり、研究開発および臨床応用の新たな扉を開くものです。

製品DBMの海綿質チップと組み合わせたパテの採用により、広範囲の骨修復が可能になります。

DBMゲルは流動性のある製剤で、脊椎固定術や特定の歯科用途など、正確な骨移植を必要とする手術に容易に適用できます。その可鍛性により、スペースと精度が最優先される低侵襲手術に適しています。DBMパテは、構造的な支持を必要とせず、最小限の介入と正確な適用を必要とする場面で好まれます。DBMパテは、手術部位に塗布し、必要に応じて形を整えることができる、より可鍛性の高いソリューションです。その汎用性により、脊椎手術、骨折修復、関節再建を含むがこれらに限定されない、さまざまな骨修復処置に広く使用されています。成長因子の運搬とある程度の成形性の両方が必要とされる幅広い外科的用途において、その汎用性と使いやすさから選ばれています。海綿骨チップ配合パテは、DBMパテに海綿骨チップを配合したもので、骨誘導性と骨伝導性の両方の特性を備えているため、大きな骨欠損の修復や大規模な再建手術など、新しい骨成長のための足場が必要な手技に理想的な選択肢となります。このチップは、成形性、安定性、骨治癒特性の向上が必要とされる広範囲の骨修復術に好まれます。

応用整形外科手術におけるDBMの急速な普及

脊椎固定術では、椎骨の癒合を促進するために脱灰骨マトリックス（DBM）が利用されます。この用途では、DBMの骨誘導特性を活用し、身体の自然な骨形成メカニズムを刺激します。融合プロセスを補助することで、DBMは脊椎の安定化を促進し、椎間板変性症、脊椎すべり症、脊柱側弯症などの患者を救済します。DBMは、歯科手術、特にインプラントや歯周病修復に伴う骨移植に重要な用途を見出しています。DBMは足場として機能し、欠損部位の新しい骨の成長をサポートするため、歯科インプラントの安定性と成功率を高め、歯周病で失われた骨の再生を助ける。整形外科では、骨欠損や骨折の治療にDBMが役立っています。DBMの骨伝導性と骨誘導性の特性は、骨の再生と修復が必要とされる場面で不可欠です。関節再建手術、特に人工股関節置換術や人工膝関節置換術におけるDBMの使用は、人工関節コンポーネントと宿主骨との一体化を促進します。DBMは人工骨コンポーネントの周囲に適用され、骨の成長を促進することで、インプラントを固定し、長期的な安定性を向上させる。頭蓋顎顔面手術では、DBMは外傷、先天性疾患、切除によって生じた骨欠損の修復に使用されます。骨形成をサポートするその能力は、この複雑な解剖学的部位の再建手術に不可欠なものであり、機能的にも審美的にも優れた結果をもたらします。

地域別の洞察

南北アメリカ、特に米国では、DBMの使用は高度に規制されているが、高度なヘルスケア・インフラと骨関連疾患の高い発生率に後押しされ、広く受け入れられています。この地域での生産はFDAの厳しい規制によって特徴付けられ、製品の安全性と有効性が確保されています。大手企業は、強固な研究開発投資と広範な販売網に支えられています。APAC市場は急成長しているが、規制状況が多様で、整形外科手術の増加に起因するニーズが高いという対照的な特徴があります。DBM製品のコスト優位性と地域ごとのカスタマイズを武器に、現地メーカーが台頭してきています。国によって規制環境が異なるEMEA市場は、欧州諸国の先進ヘルスケアシステムと中東・アフリカの新興市場がバランスよく融合しています。この地域には、世界なDBMプレーヤーと、地域のヘルスケアニーズやコンプライアンス基準に適応する現地法人の両方が強く存在していることが特徴です。これらの企業は、DBMを包括的な骨移植片のポートフォリオに加えることで、より広範な商品化を可能にしています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは、脱灰骨マトリックス市場を評価する上で極めて重要です。事業戦略や製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、脱灰骨マトリックス市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された蓄積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2.市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3.市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4.競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5.製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1.脱灰骨マトリックス市場の市場規模および予測は？

2.脱灰骨マトリックス市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3.脱灰骨マトリックス市場の技術動向と規制枠組みは？

4.脱灰骨マトリックス市場における主要ベンダーの市場シェアは？

5.脱灰骨マトリックス市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 骨損傷の増加と整形外科手術の導入
    • 整形外科調査活動を促進する政府投資
  • 抑制要因
    • 脱灰骨マトリックスの高額な費用と償還制限
  • 機会
    • 脱灰骨マトリックス素材の進歩
    • 脱灰骨マトリックスの供給に関する利害関係者間の協力
  • 課題
    • 脱灰骨マトリックスの品質と一貫性に関する懸念
• 市場セグメンテーション分析
  • 製品：広範囲の骨修復状況におけるDBMの海綿骨チップと組み合わせたパテの採用
  • 応用：整形外科手術におけるDBMの急速な導入
• 市場ディスラプション分析
• ポーターのファイブフォース分析
• バリューチェーンとクリティカルパス分析
• 価格分析
• 技術分析
• 特許分析
• 貿易分析
• 規制枠組みの分析

第6章 脱灰骨マトリックス市場：製品別

• ゲル
• パテ
• パテと海綿状チップの組み合わせ

第7章 脱灰骨マトリックス市場管理モード別

• 移植
• 注射

第8章 脱灰骨マトリックス市場：用途別

• 頭蓋顎顔面外科手術
• 歯の再建
• 関節再建
• 整形外科的修復
• 脊椎固定手術

第9章 脱灰骨マトリックス市場：最終用途別

• 病院
• 専門クリニック

第10章 南北アメリカの脱灰骨マトリックス市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域の脱灰骨マトリックス市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカの脱灰骨マトリックス市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • パラゴン28、BEAST Cortical Fibersを発売し、生物製剤ポートフォリオを拡大
  • バイオジェニックスがオステオスパンファイバーマトリックスを発売
  • ガイストリッヒが同種移植ポートフォリオの大幅な拡大を発表
• 戦略分析と提言

第14章 競争力のあるポートフォリオ

• 主要企業プロファイル
• 主要製品ポートフォリオ

LIST OF FIGURES

• FIGURE 1. DEMINERALIZED BONE MATRIX MARKET RESEARCH PROCESS
• FIGURE 2. DEMINERALIZED BONE MATRIX MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY REGION, 2023 VS 2030 (%)
• FIGURE 5. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. DEMINERALIZED BONE MATRIX MARKET DYNAMICS
• FIGURE 7. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 8. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 9. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2023 VS 2030 (%)
• FIGURE 10. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 11. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 12. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 13. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
• FIGURE 14. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 15. AMERICAS DEMINERALIZED BONE MATRIX MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 16. AMERICAS DEMINERALIZED BONE MATRIX MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 17. UNITED STATES DEMINERALIZED BONE MATRIX MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 18. UNITED STATES DEMINERALIZED BONE MATRIX MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 19. ASIA-PACIFIC DEMINERALIZED BONE MATRIX MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 20. ASIA-PACIFIC DEMINERALIZED BONE MATRIX MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA DEMINERALIZED BONE MATRIX MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 22. EUROPE, MIDDLE EAST & AFRICA DEMINERALIZED BONE MATRIX MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 23. DEMINERALIZED BONE MATRIX MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 24. DEMINERALIZED BONE MATRIX MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. DEMINERALIZED BONE MATRIX MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, 2018-2023 (USD MILLION)
• TABLE 4. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, 2024-2030 (USD MILLION)
• TABLE 5. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 6. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 7. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 8. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 9. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY GEL, BY REGION, 2018-2023 (USD MILLION)
• TABLE 10. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY GEL, BY REGION, 2024-2030 (USD MILLION)
• TABLE 11. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY PUTTY, BY REGION, 2018-2023 (USD MILLION)
• TABLE 12. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY PUTTY, BY REGION, 2024-2030 (USD MILLION)
• TABLE 13. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY PUTTY COMBINED WITH CANCELLOUS CHIPS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 14. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY PUTTY COMBINED WITH CANCELLOUS CHIPS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 15. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2023 (USD MILLION)
• TABLE 16. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2024-2030 (USD MILLION)
• TABLE 17. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY IMPLANTATION, BY REGION, 2018-2023 (USD MILLION)
• TABLE 18. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY IMPLANTATION, BY REGION, 2024-2030 (USD MILLION)
• TABLE 19. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY INJECTION, BY REGION, 2018-2023 (USD MILLION)
• TABLE 20. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY INJECTION, BY REGION, 2024-2030 (USD MILLION)
• TABLE 21. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 22. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 23. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY CRANIOMAXILLOFACIAL SURGERIES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 24. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY CRANIOMAXILLOFACIAL SURGERIES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 25. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY DENTAL RECONSTRUCTIONS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 26. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY DENTAL RECONSTRUCTIONS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 27. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY JOINT RECONSTRUCTION, BY REGION, 2018-2023 (USD MILLION)
• TABLE 28. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY JOINT RECONSTRUCTION, BY REGION, 2024-2030 (USD MILLION)
• TABLE 29. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY ORTHOPEDIC REPAIRS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 30. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY ORTHOPEDIC REPAIRS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 31. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY SPINAL FUSION SURGERY, BY REGION, 2018-2023 (USD MILLION)
• TABLE 32. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY SPINAL FUSION SURGERY, BY REGION, 2024-2030 (USD MILLION)
• TABLE 33. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 34. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 35. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 36. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 37. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 38. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 39. AMERICAS DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 40. AMERICAS DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 41. AMERICAS DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2023 (USD MILLION)
• TABLE 42. AMERICAS DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2024-2030 (USD MILLION)
• TABLE 43. AMERICAS DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 44. AMERICAS DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 45. AMERICAS DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 46. AMERICAS DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 47. AMERICAS DEMINERALIZED BONE MATRIX MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 48. AMERICAS DEMINERALIZED BONE MATRIX MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 49. ARGENTINA DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 50. ARGENTINA DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 51. ARGENTINA DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2023 (USD MILLION)
• TABLE 52. ARGENTINA DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2024-2030 (USD MILLION)
• TABLE 53. ARGENTINA DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 54. ARGENTINA DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 55. ARGENTINA DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 56. ARGENTINA DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 57. BRAZIL DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 58. BRAZIL DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 59. BRAZIL DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2023 (USD MILLION)
• TABLE 60. BRAZIL DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2024-2030 (USD MILLION)
• TABLE 61. BRAZIL DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 62. BRAZIL DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 63. BRAZIL DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 64. BRAZIL DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 65. CANADA DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 66. CANADA DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 67. CANADA DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2023 (USD MILLION)
• TABLE 68. CANADA DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2024-2030 (USD MILLION)
• TABLE 69. CANADA DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 70. CANADA DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 71. CANADA DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 72. CANADA DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 73. MEXICO DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 74. MEXICO DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 75. MEXICO DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2023 (USD MILLION)
• TABLE 76. MEXICO DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2024-2030 (USD MILLION)
• TABLE 77. MEXICO DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 78. MEXICO DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 79. MEXICO DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 80. MEXICO DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 81. UNITED STATES DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 82. UNITED STATES DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 83. UNITED STATES DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2023 (USD MILLION)
• TABLE 84. UNITED STATES DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2024-2030 (USD MILLION)
• TABLE 85. UNITED STATES DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 86. UNITED STATES DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 87. UNITED STATES DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 88. UNITED STATES DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 89. UNITED STATES DEMINERALIZED BONE MATRIX MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
• TABLE 90. UNITED STATES DEMINERALIZED BONE MATRIX MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
• TABLE 91. ASIA-PACIFIC DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 92. ASIA-PACIFIC DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 93. ASIA-PACIFIC DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2023 (USD MILLION)
• TABLE 94. ASIA-PACIFIC DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2024-2030 (USD MILLION)
• TABLE 95. ASIA-PACIFIC DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 96. ASIA-PACIFIC DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 97. ASIA-PACIFIC DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 98. ASIA-PACIFIC DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 99. ASIA-PACIFIC DEMINERALIZED BONE MATRIX MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 100. ASIA-PACIFIC DEMINERALIZED BONE MATRIX MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 101. AUSTRALIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 102. AUSTRALIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 103. AUSTRALIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2023 (USD MILLION)
• TABLE 104. AUSTRALIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2024-2030 (USD MILLION)
• TABLE 105. AUSTRALIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 106. AUSTRALIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 107. AUSTRALIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 108. AUSTRALIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 109. CHINA DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 110. CHINA DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 111. CHINA DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2023 (USD MILLION)
• TABLE 112. CHINA DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2024-2030 (USD MILLION)
• TABLE 113. CHINA DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 114. CHINA DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 115. CHINA DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 116. CHINA DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 117. INDIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 118. INDIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 119. INDIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2023 (USD MILLION)
• TABLE 120. INDIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2024-2030 (USD MILLION)
• TABLE 121. INDIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 122. INDIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 123. INDIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 124. INDIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 125. INDONESIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 126. INDONESIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 127. INDONESIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2023 (USD MILLION)
• TABLE 128. INDONESIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2024-2030 (USD MILLION)
• TABLE 129. INDONESIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 130. INDONESIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 131. INDONESIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 132. INDONESIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 133. JAPAN DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 134. JAPAN DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 135. JAPAN DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2023 (USD MILLION)
• TABLE 136. JAPAN DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2024-2030 (USD MILLION)
• TABLE 137. JAPAN DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 138. JAPAN DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 139. JAPAN DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 140. JAPAN DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 141. MALAYSIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 142. MALAYSIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 143. MALAYSIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2023 (USD MILLION)
• TABLE 144. MALAYSIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2024-2030 (USD MILLION)
• TABLE 145. MALAYSIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 146. MALAYSIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 147. MALAYSIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 148. MALAYSIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 149. PHILIPPINES DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 150. PHILIPPINES DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 151. PHILIPPINES DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2023 (USD MILLION)
• TABLE 152. PHILIPPINES DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2024-2030 (USD MILLION)
• TABLE 153. PHILIPPINES DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 154. PHILIPPINES DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 155. PHILIPPINES DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 156. PHILIPPINES DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 157. SINGAPORE DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 158. SINGAPORE DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 159. SINGAPORE DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2023 (USD MILLION)
• TABLE 160. SINGAPORE DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2024-2030 (USD MILLION)
• TABLE 161. SINGAPORE DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 162. SINGAPORE DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 163. SINGAPORE DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 164. SINGAPORE DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 165. SOUTH KOREA DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 166. SOUTH KOREA DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 167. SOUTH KOREA DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2023 (USD MILLION)
• TABLE 168. SOUTH KOREA DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2024-2030 (USD MILLION)
• TABLE 169. SOUTH KOREA DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 170. SOUTH KOREA DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 171. SOUTH KOREA DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 172. SOUTH KOREA DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 173. TAIWAN DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 174. TAIWAN DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 175. TAIWAN DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2023 (USD MILLION)
• TABLE 176. TAIWAN DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2024-2030 (USD MILLION)
• TABLE 177. TAIWAN DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 178. TAIWAN DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 179. TAIWAN DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 180. TAIWAN DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 181. THAILAND DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 182. THAILAND DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 183. THAILAND DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2023 (USD MILLION)
• TABLE 184. THAILAND DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2024-2030 (USD MILLION)
• TABLE 185. THAILAND DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 186. THAILAND DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 187. THAILAND DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 188. THAILAND DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 189. VIETNAM DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 190. VIETNAM DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 191. VIETNAM DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2023 (USD MILLION)
• TABLE 192. VIETNAM DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2024-2030 (USD MILLION)
• TABLE 193. VIETNAM DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 194. VIETNAM DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 195. VIETNAM DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 196. VIETNAM DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 197. EUROPE, MIDDLE EAST & AFRICA DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 198. EUROPE, MIDDLE EAST & AFRICA DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 199. EUROPE, MIDDLE EAST & AFRICA DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2023 (USD MILLION)
• TABLE 200. EUROPE, MIDDLE EAST & AFRICA DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2024-2030 (USD MILLION)
• TABLE 201. EUROPE, MIDDLE EAST & AFRICA DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 202. EUROPE, MIDDLE EAST & AFRICA DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 203. EUROPE, MIDDLE EAST & AFRICA DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 204. EUROPE, MIDDLE EAST & AFRICA DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 205. EUROPE, MIDDLE EAST & AFRICA DEMINERALIZED BONE MATRIX MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 206. EUROPE, MIDDLE EAST & AFRICA DEMINERALIZED BONE MATRIX MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 207. DENMARK DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 208. DENMARK DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 209. DENMARK DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2023 (USD MILLION)
• TABLE 210. DENMARK DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2024-2030 (USD MILLION)
• TABLE 211. DENMARK DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 212. DENMARK DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 213. DENMARK DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 214. DENMARK DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 215. EGYPT DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 216. EGYPT DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 217. EGYPT DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2023 (USD MILLION)
• TABLE 218. EGYPT DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2024-2030 (USD MILLION)
• TABLE 219. EGYPT DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 220. EGYPT DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 221. EGYPT DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 222. EGYPT DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 223. FINLAND DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 224. FINLAND DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 225. FINLAND DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2023 (USD MILLION)
• TABLE 226. FINLAND DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2024-2030 (USD MILLION)
• TABLE 227. FINLAND DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 228. FINLAND DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 229. FINLAND DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 230. FINLAND DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 231. FRANCE DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 232. FRANCE DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 233. FRANCE DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2023 (USD MILLION)
• TABLE 234. FRANCE DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2024-2030 (USD MILLION)
• TABLE 235. FRANCE DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 236. FRANCE DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 237. FRANCE DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 238. FRANCE DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 239. GERMANY DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 240. GERMANY DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 241. GERMANY DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2023 (USD MILLION)
• TABLE 242. GERMANY DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2024-2030 (USD MILLION)
• TABLE 243. GERMANY DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 244. GERMANY DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 245. GERMANY DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 246. GERMANY DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 247. ISRAEL DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 248. ISRAEL DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 249. ISRAEL DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2023 (USD MILLION)
• TABLE 250. ISRAEL DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2024-2030 (USD MILLION)
• TABLE 251. ISRAEL DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 252. ISRAEL DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 253. ISRAEL DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 254. ISRAEL DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 255. ITALY DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 256. ITALY DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 257. ITALY DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2023 (USD MILLION)
• TABLE 258. ITALY DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2024-2030 (USD MILLION)
• TABLE 259. ITALY DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 260. ITALY DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 261. ITALY DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 262. ITALY DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 263. NETHERLANDS DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 264. NETHERLANDS DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 265. NETHERLANDS DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2023 (USD MILLION)
• TABLE 266. NETHERLANDS DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2024-2030 (USD MILLION)
• TABLE 267. NETHERLANDS DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 268. NETHERLANDS DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 269. NETHERLANDS DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 270. NETHERLANDS DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 271. NIGERIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 272. NIGERIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 273. NIGERIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2023 (USD MILLION)
• TABLE 274. NIGERIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2024-2030 (USD MILLION)
• TABLE 275. NIGERIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 276. NIGERIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 277. NIGERIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 278. NIGERIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 279. NORWAY DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 280. NORWAY DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 281. NORWAY DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2023 (USD MILLION)
• TABLE 282. NORWAY DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2024-2030 (USD MILLION)
• TABLE 283. NORWAY DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 284. NORWAY DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 285. NORWAY DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 286. NORWAY DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 287. POLAND DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 288. POLAND DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 289. POLAND DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2023 (USD MILLION)
• TABLE 290. POLAND DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2024-2030 (USD MILLION)
• TABLE 291. POLAND DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 292. POLAND DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 293. POLAND DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 294. POLAND DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 295. QATAR DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 296. QATAR DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 297. QATAR DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2023 (USD MILLION)
• TABLE 298. QATAR DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2024-2030 (USD MILLION)
• TABLE 299. QATAR DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 300. QATAR DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 301. QATAR DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 302. QATAR DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 303. RUSSIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 304. RUSSIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 305. RUSSIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2023 (USD MILLION)
• TABLE 306. RUSSIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2024-2030 (USD MILLION)
• TABLE 307. RUSSIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 308. RUSSIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 309. RUSSIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 310. RUSSIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 311. SAUDI ARABIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 312. SAUDI ARABIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 313. SAUDI ARABIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2023 (USD MILLION)
• TABLE 314. SAUDI ARABIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2024-2030 (USD MILLION)
• TABLE 315. SAUDI ARABIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 316. SAUDI ARABIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 317. SAUDI ARABIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 318. SAUDI ARABIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 319. SOUTH AFRICA DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 320. SOUTH AFRICA DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 321. SOUTH AFRICA DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2023 (USD MILLION)
• TABLE 322. SOUTH AFRICA DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2024-2030 (USD MILLION)
• TABLE 323. SOUTH AFRICA DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 324. SOUTH AFRICA DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 325. SOUTH AFRICA DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 326. SOUTH AFRICA DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 327. SPAIN DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 328. SPAIN DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 329. SPAIN DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2023 (USD MILLION)

TA

[186 Pages Report] The Demineralized Bone Matrix Market size was estimated at USD 671.14 million in 2023 and expected to reach USD 713.36 million in 2024, at a CAGR 6.54% to reach USD 1,046.37 million by 2030.

Demineralized bone matrix (DBM) is a type of bone graft material obtained from the collagen matrix of allogeneic bone, which has had its mineral content removed through an acid extraction process. This demineralization process exposes the bone's growth factors, particularly bone morphogenetic proteins (BMPs), making DBM osteoinductive and capable of promoting new bone formation. The primary factors contributing to the expansion of DBM use include its efficacy in bone repair and regeneration, its role as a graft extender in various orthopedic, dental, and spinal surgeries, and its potential to reduce the need for autografts, thus minimizing donor site morbidity. However, the variability in osteoinductive potential between different DBM products, the potential for immunogenic reaction, and the high costs associated with some DBM preparations pose significant challenges to their adoption. To address these restraints, ongoing research, and technological advancements focus on enhancing the consistency and osteoinductive potential of DBM products. Strategies include the development of composite grafts that combine DBM with synthetic or natural biomaterials to improve structural and functional properties and the application of advanced processing and sterilization techniques to preserve biological activity while ensuring safety. Expanding applications in emerging regions and integration with next-generation biologics signify dynamic growth avenues for the DBM, opening new doors for research, development, and clinical application.

Product: Adoption of putty combined with cancellous chips form of DBM for extensive bone repair situations

DBM gel is a fluid-like formulation that allows for easy application in surgeries requiring precise bone graft placement, such as spinal fusion and certain dental applications. Its malleability makes it well-suited for minimally invasive procedures where space and precision are paramount. They are preferred in scenarios requiring minimal intervention and precise application without structural support. DBM putty offers a more malleable solution that can be applied to the surgical site and shaped as needed. Its versatility makes it widely used in a variety of bone repair procedures, including, but not limited to, spinal surgeries, fracture repair, and joint reconstruction. They are chosen for their versatility and ease of use in a broad range of surgical applications where both the delivery of growth factors and some degree of moldability are required. Putty combined with cancellous chips form combines DBM putty with cancellous bone chips, offering both osteoinductive and osteoconductive properties, making it an ideal choice for procedures requiring a scaffold for new bone growth, such as large bone defect repair and major reconstructive surgeries. They are preferred in extensive bone repair procedures where a blend of moldability, stability, and enhanced bone healing properties are needed.

Application: Exponential adoption of DBM for orthopedic surgical procedures

In spinal fusion surgery, a demineralized bone matrix (DBM) is utilized to promote the fusion of vertebrae. This application leverages the osteoinductive properties of DBM, which stimulate the body's natural bone-forming mechanisms. By aiding in the fusion process, DBM facilitates the stabilization of the spine, offering relief to patients with conditions such as degenerative disc disease, spondylolisthesis, and scoliosis. DBM finds significant applications in dental surgery, particularly in bone grafting procedures associated with dental implants and periodontal disease repair. It acts as a scaffold, supporting new bone growth in areas of deficiency, thus enhancing the stability and success rate of dental implants and aiding in the regeneration of bone lost to periodontal disease. Orthopedic surgery benefits from DBM in the treatment of bone defects and fractures. DBM's osteoconductive and osteoinductive characteristics are vital in scenarios where bone regeneration and repair are required. The use of DBM in joint reconstruction surgeries, particularly in hip and knee replacements, enhances the integration of the prosthetic components with the host bone. It is applied around the prosthetic components to promote bone ingrowth, thereby securing the implant and improving its long-term stability. In craniomaxillofacial procedures, DBM is used to repair bone defects resulting from trauma, congenital conditions, or resections. Its ability to support bone formation makes it an integral part of reconstructive surgeries in this complex anatomical region, contributing to both functional and aesthetic outcomes.

Regional Insights

In the Americas, particularly the United States, the use of DBM is highly regulated but widely accepted, driven by an advanced healthcare infrastructure and a high incidence of bone-related disorders. Production in this region is characterized by stringent FDA regulations, ensuring product safety and efficacy. Major companies are backed by robust R&D investments and expansive distribution networks. The APAC market, while rapidly growing, presents a contrast with a diverse regulatory landscape and a high need stemming from increasing orthopedic surgeries. Local manufacturers are emerging, leveraging cost advantages and regional customization of DBM products. The EMEA market, with its diverse regulatory environment across countries, shows a balanced blend of advanced healthcare systems in European countries and emerging markets in the Middle East and Africa. The region is marked by a strong presence of both global DBM players and local entities adapting to regional healthcare needs and compliance standards. They are working on including DBM with their comprehensive bone graft portfolio, enabling its wider commercialization.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Demineralized Bone Matrix Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Demineralized Bone Matrix Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Demineralized Bone Matrix Market, highlighting leading vendors and their innovative profiles. These include Advanced Biotech Products P Ltd, AlloSource, Arthrex, Inc., Bioventus LLC, Cerapedics.Inc., Curasan AG, Exactech, Inc., Geistlich Pharma AG, Globus Medical, HansBioMed., Institut Straumann AG, Integra LifeSciences Holdings Corporation, Johnson & Johnson Services, Inc., KLS Martin SE & Co. KG, Kuros Biosciences Ltd., Medtronic PLC, NovaBone by Halma PLC, Orthofix Medical Inc., Osteogenics Biomedical, RTI Surgical Holdings, Inc., SpineWave, Inc., Stryker Corporation, Synerheal, XTANT Medical, and Zimmer Biomet.

Market Segmentation & Coverage

This research report categorizes the Demineralized Bone Matrix Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Product
  • Gel
  • Putty
  • Putty Combined with Cancellous Chips

• Administration Mode
  • Implantation
  • Injection

• Application
  • Craniomaxillofacial Surgeries
  • Dental Reconstructions
  • Joint Reconstruction
  • Orthopedic Repairs
  • Spinal Fusion Surgery

• End-Use
  • Hospitals
  • Specialty Clinics

• Region
  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam

• Europe, Middle East & Africa
  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Demineralized Bone Matrix Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Demineralized Bone Matrix Market?

3. What are the technology trends and regulatory frameworks in the Demineralized Bone Matrix Market?

4. What is the market share of the leading vendors in the Demineralized Bone Matrix Market?

5. Which modes and strategic moves are suitable for entering the Demineralized Bone Matrix Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing prevalence of bone injuries and adoption of orthopedic surgeries
    • 5.1.1.2. Government investments promoting orthopedic research activities
  • 5.1.2. Restraints
    • 5.1.2.1. High cost and reimbursement limitations of demineralized bone matrix
  • 5.1.3. Opportunities
    • 5.1.3.1. Advancements in the demineralized bone matrix materials
    • 5.1.3.2. Collaboration between stakeholders for supply of demineralized bone matrix
  • 5.1.4. Challenges
    • 5.1.4.1. Quality and consistency concerns of demineralized bone matrix
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Adoption of putty combined with cancellous chips form of DBM for extensive bone repair situations
  • 5.2.2. Application: Exponential adoption of DBM for orthopedic surgical procedures
• 5.3. Market Disruption Analysis
• 5.4. Porter's Five Forces Analysis
  • 5.4.1. Threat of New Entrants
  • 5.4.2. Threat of Substitutes
  • 5.4.3. Bargaining Power of Customers
  • 5.4.4. Bargaining Power of Suppliers
  • 5.4.5. Industry Rivalry
• 5.5. Value Chain & Critical Path Analysis
• 5.6. Pricing Analysis
• 5.7. Technology Analysis
• 5.8. Patent Analysis
• 5.9. Trade Analysis
• 5.10. Regulatory Framework Analysis

6. Demineralized Bone Matrix Market, by Product

• 6.1. Introduction
• 6.2. Gel
• 6.3. Putty
• 6.4. Putty Combined with Cancellous Chips

7. Demineralized Bone Matrix Market, by Administration Mode

• 7.1. Introduction
• 7.2. Implantation
• 7.3. Injection

8. Demineralized Bone Matrix Market, by Application

• 8.1. Introduction
• 8.2. Craniomaxillofacial Surgeries
• 8.3. Dental Reconstructions
• 8.4. Joint Reconstruction
• 8.5. Orthopedic Repairs
• 8.6. Spinal Fusion Surgery

9. Demineralized Bone Matrix Market, by End-Use

• 9.1. Introduction
• 9.2. Hospitals
• 9.3. Specialty Clinics

10. Americas Demineralized Bone Matrix Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Demineralized Bone Matrix Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Demineralized Bone Matrix Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
  • 13.3.1. Paragon 28 Launches BEAST Cortical Fibers Expanding its Biologics Portfolio
  • 13.3.2. Biogennix Launches OsteoSPAN Fiber Matrix
  • 13.3.3. Geistlich Announces The Dramatic Expansion Of Their Allograft Portfolio
• 13.4. Strategy Analysis & Recommendation

14. Competitive Portfolio

• 14.1. Key Company Profiles
• 14.2. Key Product Portfolio